Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arash Sadri

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annals of Neurology|February 21, 2018
Excess amyloid beta can be degraded in healthy humansArash Sadri
Current Drug Metabolism|April 6, 2019
Letter to the Editor on "A System Pharmacology Study for Deciphering Anti Depression Activity of Nardostachys jatamansi"Arash Sadri
Journal of Medicinal Chemistry|September 6, 2023
Is Target-Based Drug Discovery Efficient? Discovery and "Off-Target" Mechanisms of All DrugsArash Sadri
Future Medicinal Chemistry|April 18, 2025
Evidence-based drug discoveryArash Sadri
The Behavioral and Brain Sciences|May 13, 2024
Reductionism and proxy failure: From neuroscience to target-based drug discoveryArash Sadri, Sepideh Paknezhad
Molecular Biology Reports|March 7, 2025
Dead-End protein expression, function, and mutation in cancer: a systematic reviewHoma Faraji, Farnaz Banakar, Arash Sadri, et al.
Arxiv|May 22, 2023
Reproducible biomarkers: Leveraging nonlinear descriptors in the face of non-ergodicityMadhur Mangalam, Arash Sadri, Junichiro Hayano, et al.
Bioorganic Chemistry|July 13, 2023
Arylureidoaurones: Synthesis, in vitro α-glucosidase, and α-amylase inhibition activityMohammad Kazempour-Dizaji, Somayeh Mojtabavi, Arash Sadri, et al.
Scientific Reports|October 25, 2023
Multifractal foundations of biomarker discovery for heart disease and strokeMadhur Mangalam, Arash Sadri, Junichiro Hayano, et al.
Journal of Ethnopharmacology|March 31, 2023
Evaluation of acute and sub-chronic oral toxicities of Neoneaster in ratsNima Aramipour, Maryam Gholami, Mohammad Saber, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annals of Neurology|February 21, 2018
Excess amyloid beta can be degraded in healthy humansArash Sadri
Current Drug Metabolism|April 6, 2019
Letter to the Editor on "A System Pharmacology Study for Deciphering Anti Depression Activity of Nardostachys jatamansi"Arash Sadri
Journal of Medicinal Chemistry|September 6, 2023
Is Target-Based Drug Discovery Efficient? Discovery and "Off-Target" Mechanisms of All DrugsArash Sadri
Future Medicinal Chemistry|April 18, 2025
Evidence-based drug discoveryArash Sadri
The Behavioral and Brain Sciences|May 13, 2024
Reductionism and proxy failure: From neuroscience to target-based drug discoveryArash Sadri, Sepideh Paknezhad
Molecular Biology Reports|March 7, 2025
Dead-End protein expression, function, and mutation in cancer: a systematic reviewHoma Faraji, Farnaz Banakar, Arash Sadri, et al.
Arxiv|May 22, 2023
Reproducible biomarkers: Leveraging nonlinear descriptors in the face of non-ergodicityMadhur Mangalam, Arash Sadri, Junichiro Hayano, et al.
Bioorganic Chemistry|July 13, 2023
Arylureidoaurones: Synthesis, in vitro α-glucosidase, and α-amylase inhibition activityMohammad Kazempour-Dizaji, Somayeh Mojtabavi, Arash Sadri, et al.
Scientific Reports|October 25, 2023
Multifractal foundations of biomarker discovery for heart disease and strokeMadhur Mangalam, Arash Sadri, Junichiro Hayano, et al.
Journal of Ethnopharmacology|March 31, 2023
Evaluation of acute and sub-chronic oral toxicities of Neoneaster in ratsNima Aramipour, Maryam Gholami, Mohammad Saber, et al.
Pageof 2